0001209191-15-056900.txt : 20150626
0001209191-15-056900.hdr.sgml : 20150626
20150626174731
ACCESSION NUMBER: 0001209191-15-056900
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150625
FILED AS OF DATE: 20150626
DATE AS OF CHANGE: 20150626
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRINT PAUL C
CENTRAL INDEX KEY: 0001236548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 15956243
MAIL ADDRESS:
STREET 1: 3030 CALLAN RD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-25
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001236548
GRINT PAUL C
C/O REGULUS THERAPEUTICS INC.
3545 JOHN HOPKINS CT., #210
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Stock Option (Right to Buy)
10.22
2015-06-25
4
A
0
500000
0.00
A
2025-06-24
Common Stock
500000
500000
D
Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant.
Christopher Aker, Attorney-in-Fact
2015-06-26